John Chaddock
41Patents
12h-index
21Co-inventors
81Inventor score
Filing activity: Oct 7, 1998 → May 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6632440B1 | Methods and compounds for the treatment of mucus hypersecretion | Emerging Cross-Sectional Technologies | 163 | Expired |
| US7192596B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 81 | Expired |
| US7052702B1 | Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics | Human Necessities | 50 | Expired |
| US7658933B2 | Non-cytotoxic protein conjugates | Chemistry; Metallurgy | 33 | Active |
| US7452543B2 | Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics | Human Necessities | 31 | Expired |
| US7659092B2 | Fusion proteins | Chemistry; Metallurgy | 31 | Active |
| US8067200B2 | Fusion proteins | Chemistry; Metallurgy | 29 | Active |
| US8187834B2 | Non-cytotoxic protein conjugates | Chemistry; Metallurgy | 23 | Active |
| US7208466B1 | Use of a lectin or conjugates for modulation of c-fibre activity | Human Necessities | 22 | Expired |
| US7727538B2 | Methods and compounds for the treatment of mucus hypersecretion | Chemistry; Metallurgy | 17 | Active |
| US8603779B2 | Non-cytotoxic protein conjugates | Chemistry; Metallurgy | 16 | Active |
| US8512984B2 | Non-cytotoxic protein conjugates | Chemistry; Metallurgy | 14 | Active |
| US8399401B2 | Fusion proteins | Chemistry; Metallurgy | 12 | Active |
| US7193066B1 | Preparation of highly pure toxin fragments | Emerging Cross-Sectional Technologies | 11 | Expired |
| US8124074B2 | Fusion proteins | Chemistry; Metallurgy | 10 | Active |
| US9243301B2 | Fusion proteins | Chemistry; Metallurgy | 10 | Active |
| US8399400B2 | Fusion proteins | Chemistry; Metallurgy | 9 | Active |
| US8778634B2 | Non-cytotoxic protein conjugates | Chemistry; Metallurgy | 8 | Active |
| US8940870B2 | Fusion proteins | Chemistry; Metallurgy | 8 | Active |
| US9072736B2 | Treatment of pain | Chemistry; Metallurgy | 6 | Active |
| US8790897B2 | Treatment of mucus hypersecretion | Chemistry; Metallurgy | 6 | Active |
| US7674470B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 6 | Active |
| US8372615B2 | Fusion proteins | Chemistry; Metallurgy | 5 | Active |
| US7897158B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 5 | Active |
| US8124405B2 | Fusion proteins | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.